Unknown

Dataset Information

0

Circulating 25-hydroxyvitamin D concentration can predict bowel resection risk among individuals with inflammatory bowel disease in a longitudinal cohort with 13 years of follow-up.


ABSTRACT:

Background

Although the beneficial properties of vitamin D in anti-inflammation and immunity-modulation are promising in the management of inflammatory bowel disease (IBD), data were limited for the critical IBD prognosis. The association between serum vitamin D levels and the risk of bowel resection in individuals with IBD remains largely unknown.

Materials and methods

We performed a longitudinal cohort study among 5474 individuals with IBD in the UK Biobank. Serum 25-hydroxyvitamin D [25(OH)D] was measured using direct competitive chemiluminescent immunoassay. Bowel resection events were ascertained via national inpatient data. Multivariable-adjusted Cox proportional hazard regression was used to examine the association between serum 25(OH)D and bowel resection risk, presented with hazard ratios (HRs) and 95% confidence intervals (CIs). Restricted cubic spline (RCS) was used to evaluate dose-response associations.

Results

During a mean follow-up of 13.1 years, we documented 513 incident bowel resection cases. Compared to participants with vitamin D deficiency, non-deficient participants showed a significantly reduced bowel resection risk in IBD (HR 0.72, 95% CI 0.59-0.87, P=0.001), Crohn's disease (CD, HR 0.74, 95% CI 0.56-0.98, P=0.038), and ulcerative colitis (UC, HR 0.73, 95% CI 0.57-0.95, P=0.020). When comparing extreme quintiles of 25(OH)D level, participants with IBD showed a 34% reduced risk of bowel resection (95% CI 11%-51%, P=0.007) and participants with UC showed a 46% reduced risk (95% CI 19%-64%, P=0.003), while this association was not significant in CD (HR 0.93, 95% CI 0.59-1.45, P=0.740). Linear dose-response associations were observed using the RCS curve (all P-nonlinearity>0.05).

Conclusion

Increased serum level of 25(OH)D is independently associated with reduced bowel resection risk in IBD. This association was significant in UC but may not be stable in CD. Vitamin D deficiency is a risk factor for bowel resection in individuals with IBD, and may be an effective metric in predicting and risk-screening surgical events.

SUBMITTER: Dan L 

PROVIDER: S-EPMC11254237 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Circulating 25-hydroxyvitamin D concentration can predict bowel resection risk among individuals with inflammatory bowel disease in a longitudinal cohort with 13 years of follow-up.

Dan Lintao L   Wang Sidan S   Chen Xuejie X   Sun Yuhao Y   Fu Tian T   Deng Minzi M   Chen Jie J   Du Zhongyan Z   Wang Xiaoyan X  

International journal of surgery (London, England) 20240701 7


<h4>Background</h4>Although the beneficial properties of vitamin D in anti-inflammation and immunity-modulation are promising in the management of inflammatory bowel disease (IBD), data were limited for the critical IBD prognosis. The association between serum vitamin D levels and the risk of bowel resection in individuals with IBD remains largely unknown.<h4>Materials and methods</h4>The authors performed a longitudinal cohort study among 5474 individuals with IBD in the UK Biobank. Serum 25-hy  ...[more]

Similar Datasets

| S-EPMC11238440 | biostudies-literature
| S-EPMC5741144 | biostudies-literature
| S-EPMC4827350 | biostudies-literature
| S-EPMC3524394 | biostudies-literature
| S-EPMC6294653 | biostudies-literature
| S-EPMC6167253 | biostudies-literature
| S-EPMC9569054 | biostudies-literature
| S-EPMC8116771 | biostudies-literature
| S-EPMC8564673 | biostudies-literature
| S-EPMC4526455 | biostudies-literature